Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1

Pediatric Transplantation

Volumn 9, Issue 4, 2005, Pages 534-536

  Savaşan, Süreyya ^a,b   Smith, Laurie ^b   Scheer, Carolyn ^a   Dansey, Roger ^b   Abella, Esteban ^a,b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Bone marrow transplantation; Mast cells; Neurofibromatosis type 1; Xanthogranuloma disseminatum

Indexed keywords

B7 ANTIGEN; BASILIXIMAB; BLOOD CLOTTING FACTOR 13A; CARMUSTINE; CD28 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; CD71 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FASCIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERFORIN; PROTEIN S 100; STEROID; T6 ANTIGEN;

ANEMIA; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; COUGHING; CROUP; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEPATOMEGALY; HISTIOCYTE; HUMAN; LIVER FIBROSIS; NATURAL KILLER CELL; NEUROFIBROMATOSIS; PRESCHOOL CHILD; RESPIRATORY DISTRESS; THROMBOCYTOPENIA; XANTHOGRANULOMA; XANTHOGRANULOMA DISSEMINATUM;

BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; FEMALE; HUMANS; NEUROFIBROMATOSIS 1; TRANSPLANTATION CONDITIONING; XANTHOGRANULOMA, JUVENILE;

EID: 23844439559     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00307.x     Document Type: Article

References (11)

1. ZVULUNOV A, BARAK Y, METZKER A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol 1995: 131: 904-908.
2. FREYER DR, KENNEDY R, BOSTROM BC, KOHUT G, DEHNER LP. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr 1996: 29: 227-237.
3. KOBAYASHI K, IMAT T, ADACHI S, et al. Juvenile xanthogranuloma with hematologic changes in dizygotic twins: report of two newborn infants. Pediatr Dermatol 1998: 15: 203-206.
4. MANN RE, FRIEDMAN KJ, MILGRAUM SS. Urticaria pigmentosa and juvenile xanthogranuloma: case report and brief review of the literature. Pediatr Dermatol 1996: 13: 122-126.
5. NURNBERGER M, MOLL I. Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 5. Dermatology 1994: 188: 296-299.
6. INGRAM DA, YANG FC, TRAVERS JB, et al. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 2000: 191: 181-188.
7. ERICSON KG, FADEEL B, NILSSON-ARDNOR S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet 2001: 68: 590-597.
8. RONCHESE F, HERMANS IF. Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med 2001: 194: F23-F26.
9. HENTER JI, SAMUELSSON-HORNE A, ARICO M, et al. Histocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002: 100: 2367-2373.
10. KINUGAWA N, IMASHUKU S, HIROTA Y, et al. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant 1999: 24: 935-938.
11. SCHMID I, REITER K, SCHUSTER F, et al. Allogeneic bone marrow transplantation for active Epstein-Barr virus-related lymphoproliferative disease and hemophagocytic lymphohistiocytosis in an infant with severe combined immunodeficiency syndrome. Bone Marrow Transplant 2002: 29: 519-521.